Skip to Content
Merck

Furosemide in acute decompensated heart failure.

Prescrire international (2013-02-02)
ABSTRACT

In a comparative clinical trial in 308 patients with acute decompensated heart failure, the relief achieved with intravenous furosemide at a dose equivalent to the daily oral dose patients were receiving prior to the acute episode was very similar to that obtained with higher doses of intravenous furosemide. Increasing the dose of intravenous furosemide did not improve the outcome.

MATERIALS
Product Number
Brand
Product Description

Supelco
Furosemide solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Furosemide, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Furosemide
Supelco
Furosemide, Pharmaceutical Secondary Standard; Certified Reference Material